Table 2.
Univariate | Multivariate | |||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Age group | ||||
10–19 | 1 (Reference) | 1 (Reference) | ||
20–29 | 1.88 (1.64–2.15) | < .001 | 1.88 (1.64–2.16) | < .001 |
30–39 | 2.17 (1.90–2.47) | < .001 | 2.06 (1.81–2.36) | < .001 |
40–49 | 2.45 (2.16–2.78) | < .001 | 2.16 (1.90–2.45) | < .001 |
50 and more | 6.64 (5.93–7.45) | < .001 | 4.27 (3.79–4.82) | < .001 |
Region of residence | ||||
Rural | 1.09 (1.05–1.14) | < .001 | 1.10 (1.05–1.15) | < .001 |
Urban | 1 (Reference) | 1 (Reference) | ||
Household income | ||||
0–30% | 0.95 (0.89–1.01) | .07 | 0.83 (0.78–0.88) | < .001 |
30–70% | 0.87 (0.83–0.92) | < .001 | 0.90 (0.86–0.95) | < .001 |
70–100% | 1 (Reference) | 1 (Reference) | ||
Comorbidity | ||||
Hypertension | 3.72 (3.56–3.88) | < .001 | 1.59 (1.50–1.69) | < .001 |
Diabetes | 3.38 (3.22–3.54) | < .001 | 1.43 (1.35–1.51) | < .001 |
Chronic kidney disease | 2.61 (2.44–2.79) | < .001 | 1.26 (1.18–1.36) | < .001 |
PCOS | 1.78 (1.22–2.57) | .003 | 2.79 (1.92–4.05) | < .001 |
Behcet’s disease | 7.83 (6.40–9.60) | < .001 | 5.47 (4.43–6.76) | < .001 |
Juvenile idiopathic arthritis | 2.56 (1.28–5.12) | .008 | 3.31 (1.58–6.94) | .002 |
Ankylosing spondylitis | 3.51 (3.00–4.10) | < .001 | 1.62 (1.37–1.90) | < .001 |
Systemic lupus erythematosus | 2.46 (1.83–3.30) | < .001 | 1.53 (1.13–2.06) | .005 |
Ulcerative colitis | 1.76 (1.30–2.38) | < .001 | 1.03 (0.76–1.40) | .85 |
Tuberculosis | 2.04 (1.80–2.31) | < .001 | 1.29 (1.13–1.46) | < .001 |
Sarcoidosis | 11.37 (6.46–20.00) | < .001 | 6.06 (3.35–10.95) | < .001 |
Crohn’s disease | 2.24 (1.58–3.16) | < .001 | 1.24 (0.86–1.79) | .24 |
Multiple sclerosis | 2.75 (1.31–5.78) | .007 | 1.30 (0.58–2.89) | .52 |
Reactive arthritis | 2.48 (1.86–3.31) | < .001 | 1.50 (1.13–2.00) | .006 |
Ref Reference, PCOS Polycystic ovary syndrome, HR Hazard ratio.